Improving Uptake of Surveillance in Colorectal Cancer Survivors Through Navigation and Web Education
NCT ID: NCT06995924
Last Updated: 2025-11-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
75 participants
INTERVENTIONAL
2025-12-01
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients are assigned to 1 of 3 arms based on the clinic location they receive cancer care at.
ARM A (VIRGINIA MASON): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection for stage I-III CRC.
ARM B (FRED HUTCH \[SOUTH LAKE UNION\]): Patients receive access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.
ARM C (FRED HUTCH \[OVERLAKE\]): Patients receive access to navigation services, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the CTAC intervention, which includes self-directed, interactive web-based education about surveillance and a checklist of care, within 3 months of standard of care surgical resection for stage I-III CRC.
Patients are followed up at 3 and 9 months post study-enrollment and 12-18 months after surgical resection.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm A (navigation)
Patients at the Virginia Mason clinic location receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, within 3 months of standard of care surgical resection.
Electronic Health Record Review
Ancillary studies
Patient Navigation
Receive patient navigation services
Survey Administration
Ancillary studies
Arm B (CTAC)
Patients at the Fred Hutch (South Lake Union) clinic location receive access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.
Educational Intervention
Complete self-directed interactive education
Electronic Health Record Review
Ancillary studies
Internet-Based Intervention
Receive access to CTAC
Survey Administration
Ancillary studies
Arm C (navigation and CTAC)
Patients at the Fred Hutch (Overlake) clinic location receive access to navigation services, in person, via telephone or via electronic conferencing platform, including education on surveillance care, reminders to complete care and assistance in scheduling surveillance, and access to the online CTAC intervention, which includes self-directed, interactive education about surveillance and a checklist of care, within 3 months of standard of care surgical resection.
Educational Intervention
Complete self-directed interactive education
Electronic Health Record Review
Ancillary studies
Internet-Based Intervention
Receive access to CTAC
Patient Navigation
Receive patient navigation services
Survey Administration
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Educational Intervention
Complete self-directed interactive education
Electronic Health Record Review
Ancillary studies
Internet-Based Intervention
Receive access to CTAC
Patient Navigation
Receive patient navigation services
Survey Administration
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stage I-III CRC survivor within 3 months post-surgical resection
* Being seen at a participating clinic
* Ability to understand and complete surveys in English
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fred Hutchinson Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rachel B. Issaka, MD, MAS
Role: PRINCIPAL_INVESTIGATOR
Fred Hutch/University of Washington Cancer Consortium
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Benaroya Research Institute at Virginia Mason
Seattle, Washington, United States
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Ari Bell-Brown
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NCI-2025-03304
Identifier Type: REGISTRY
Identifier Source: secondary_id
20875
Identifier Type: OTHER
Identifier Source: secondary_id
RG1125283
Identifier Type: -
Identifier Source: org_study_id